Atlas Trials

Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder

Clinical trial NCT02909959 · COMPLETED

Trial details

NCT number
NCT02909959
Sponsor
University of North Carolina, Chapel Hill
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Autism Spectrum DisorderAutistic DisorderNeurodevelopmental DisorderChildhood Developmental Disorders, Pervasive
Start date
2017-03-01
Primary completion
2019-05-30
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.